Researchers Funded by The Leukemia & Lymphoma Society Present Innovative Science at American Association for Cancer Research Annual Meeting 2013
4/4/2013 12:11:13 PM
More...
|
The Leukemia & Lymphoma Society Announces Expanded Role for Mark Velleca, M.D., Ph.D., Chief Policy and Advocacy Officer
3/8/2013 9:17:37 AM
More...
|
Quest for Cures: The Leukemia & Lymphoma Society Seeks to Fund Three Critical Areas of Blood Cancer Research
3/1/2013 9:32:56 AM
More...
|
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
2/19/2013 12:43:24 PM
More...
|
The Leukemia & Lymphoma Society Awards $1.68 Million to Improve Outcomes for Patients With Acute Promyelocytic Leukemia
1/25/2013 9:11:24 AM
More...
|
Curis, Inc. (CRIS) Achieves CUDC-907 Milestones Under Its Agreement With The Leukemia & Lymphoma Society
10/18/2012 9:12:43 AM
More...
|
Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9/20/2012 10:22:54 AM
More...
|
The Leukemia & Lymphoma Society Awards Four Major Grants to Acclaimed Researchers
9/6/2012 12:15:25 PM
More...
|
The Leukemia & Lymphoma Society and Celator Pharmaceuticals, Inc. Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
7/5/2012 10:00:24 AM
More...
|
The Leukemia & Lymphoma Society Release: Deal Announced Today Between Celgene Corporation (CELG) and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia
4/27/2012 9:16:38 AM
More...
|
|